Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.46 |
| ▸ | MEN1 | O00255 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6535929 | 0.90 | MAPT (0.43) | MAPTMEN1KMT2ATDP1GAA | |
| SCHEMBL30392107 | 0.90 | MAPT (0.43) | MAPTMEN1KMT2ATDP1GAA | |
| SCHEMBL1650229 | 0.88 | KCNH3 (0.42) | MAPTMEN1KMT2ATDP1GAA | |
| SCHEMBL8680807 | 0.88 | KCNH3 (0.42) | MAPTMEN1KMT2ATDP1GAA | |
| SCHEMBL3796679 | 0.86 | MAPT (0.48) | MAPTMEN1KMT2ATDP1GAA | |
| SCHEMBL28958671 | 0.83 | MAPT (0.46) | MAPTMEN1KMT2ATDP1GAA | |
| SCHEMBL23609331 | 0.83 | MAPT (0.42) | MAPTMEN1KMT2ATDP1GAA | |
| SCHEMBL2904304 | 0.80 | ALDH1A1 (0.42) | MAPTMEN1KMT2ATDP1GAA | |
| SCHEMBL24526452 | 0.79 | SLC18A1 (0.36) | MAPTTDP1ALDH1A1CYP3A4AR | |
| SCHEMBL3895691 | 0.79 | ALDH1A1 (0.46) | MAPTMEN1KMT2ATDP1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9951205-B2 | Stable compositions of thiabendazole and iodine-containing fungicides | LANXESS DEUTSCHLAND GMBH (DE) | 2018-04-24 | — | — | US | disclosed |
| EP-2413697-B1 | STABILISATION OF COMPOUNDS CONTAINING IODINE | LANXESS DEUTSCHLAND GMBH (DE) | 2017-11-08 | — | — | EP | disclosed |
| EP-2779830-B1 | STABILIZATION OF COMPOUNDS CONTAINING IODINE HAVING POLYMERS COMPRISING NITROGEN | LANXESS DEUTSCHLAND GMBH (DE) | 2017-05-17 | — | — | EP | disclosed |
| US-9585384-B2 | Stabilization of compounds comprising iodine | LANXESS DEUTSCHLAND GMBH (DE) | 2017-03-07 | — | — | US | disclosed |
| WO-2017025172-A1 | RUBBER COMPOSITIONS WITH LOW CONTENT OF ZINC OXIDE | HUMBOLDT-UNIVERSITÄT ZU BERLIN (DE) | 2017-02-16 | — | — | WO | disclosed |
| EP-3130630-A1 | RUBBER COMPOSITIONS WITH LOW CONTENT OF ZINC OXIDE | Humboldt Universität zu Berlin (DE) | 2017-02-15 | — | — | EP | disclosed |
| EP-3060412-A1 | RUBBER COMPOSITION | ARLANXEO Deutschland GmbH (DE) | 2016-08-31 | — | — | EP | disclosed |
| US-9326502-B2 | Stabilization of compounds containing iodine having polymers comprising nitrogen | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | disclosed |
| US-9328065-B2 | Nitrogen-containing inorganic carrier materials | LANXESS DEUTSCHLAND GMBH (DE) | 2016-05-03 | — | — | US | disclosed |
| US-9296878-B2 | Fungicide formulations for plasticized PVC | LANXESS DEUTSCHLAND GMBH (DE) | 2016-03-29 | — | — | US | disclosed |
| EP-2236033-A1 | Stabilisation of compounds containing iodine | LANXESS Deutschland GmbH (DE) | 2010-10-06 | — | — | EP | disclosed |
| US-20090192219-A1 | STABILIZATION OF IODINE-CONTAINING BIOCIDES BY MEANS OF SPECIAL AZOLE COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2009-07-30 | — | — | US | disclosed |
| US-20090036555-A1 | Stabilization of iodine biocides | LANXESS DEUTSCHLAND GMBH (DE) | 2009-02-05 | — | — | US | disclosed |
| EP-1993362-A1 | STABILIZATION OF IODINE-CONTAINING BIOCIDES BY MEANS OF SPECIAL AZOLE COMPOUNDS | Lanxess Deutschland GmbH & Co.KG (DE) | 2008-11-26 | — | — | EP | disclosed |
| EP-1926367-A1 | STABILIZATION OF IODINE BIOCIDES | Lanxess Deutschland GmbH & Co.KG (DE) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007101549-A1 | STABILIZATION OF IODINE-CONTAINING BIOCIDES BY MEANS OF SPECIAL AZOLE COMPOUNDS | LANXESS DEUTSCHLAND GMBH (DE) | 2007-09-13 | — | — | WO | disclosed |
| WO-2007028527-A1 | STABILIZATION OF IODINE BIOCIDES | LANXESS DEUTSCHLAND GMBH (DE) | 2007-03-15 | — | — | WO | disclosed |
| EP-0251791-B1 | ELASTOMERIC COMPOSITIONS | BICC Public Limited Company (GB) | 1992-01-15 | — | — | EP | disclosed |
| EP-0302007-A1 | Hydroxyether-carboxylic acids and lactones thereof, process for their production and their use as corrosion inhibitors | CIBA-GEIGY AG (CH) | 1989-02-01 | — | — | EP | disclosed |
| EP-0251792-A2 | Elastomeric compositions and methods of making them | BICC Public Limited Company (GB) | 1988-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036555-A1 | Stabilization of iodine biocides | LCT, BTD, HDHD5 | MAPT 592/4885MEN1 4571/4885KMT2A 217/4885 |
| US-20090192219-A1 | STABILIZATION OF IODINE-CONTAINING BIOCIDES BY MEANS OF SPECIAL AZOLE COMPOUNDS | LCT, BTD, ALKBH3 | MAPT 666/4885MEN1 1981/4885KMT2A 608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.